EMC3

EMC3 is a subunit of the ER membrane protein complex that drives the biogenesis of polytopic and multi-transmembrane client proteins, and its loss across many specialized secretory and epithelial cell types triggers the unfolded protein response and ER stress (PMID:29083321, PMID:33785873). Its documented clients span surfactant proteins SP-B and SP-C and the lipid transporter ABCA3 in alveolar type 2 cells (PMID:29083321), the Wnt receptor FZD4 in retinal endothelium where EMC3 thereby governs Norrin/β-catenin signaling and retinal angiogenesis (PMID:34128175), CFTR in intestinal epithelium where EMC3 also supports calcium ATPase pumps and CFTR-dependent secretion (PMID:39641142), and the lipid-droplet biogenesis regulator FITM2 in liver and adipose tissue, linking EMC3 to triglyceride storage and thermogenesis. Through this client-folding role EMC3 is required for differentiation and survival of exocrine secretory lineages and neural cell types, with loss producing mislocalization of junction, polarity, and synaptic proteins, apoptosis, and tissue degeneration (PMID:33785873, PMID:33605987, PMID:32886670). Beyond the ER, EMC3 localizes to mitotic centrosomes and, together with VCP, controls Aurora A kinase levels and activity to regulate spindle assembly and cell cycle progression (PMID:36624844), and it physically associates with VCP and its interactors to modulate trafficking and mitochondrial integrity in alveolar cells (PMID:39405113).

1. 2017 High

   Established that EMC3 is required for ER-based biogenesis of secretory machinery in vivo, defining its role in client protein processing and ER homeostasis.

   Evidence Conditional Emc3 knockout in murine lung epithelium with transcriptomic, lipidomic, and proteomic profiling

   PMID:29083321

   Open questions at the time

   • Direct insertase activity on SP-B/SP-C/ABCA3 not reconstituted biochemically
   • Stoichiometry of EMC3 within the EMC not addressed in this study
2. 2020 Medium

   Showed EMC3 is dispensable for development but required for long-term survival of neurons, distinguishing maintenance from differentiation roles.

   Evidence Bipolar cell-specific conditional knockout (Pcp2-Cre) with ERG and synaptic marker immunostaining

   PMID:32886670

   Open questions at the time

   • Specific membrane client(s) underlying mGluR6 mislocalization not identified
   • Single lab, single cell type
3. 2021 Medium

   Extended EMC3 client biology to signaling and epithelial integrity by linking it to FZD4/Wnt signaling, secretory lineage differentiation, and junction/polarity protein localization.

   Evidence Endothelial-, intestinal-, and retinal-specific conditional knockouts with RNA-seq, luciferase reporter, ER-stress pharmacological rescue, immunofluorescence, and proteomics

   PMID:33605987 PMID:33785873 PMID:34128175

   Open questions at the time

   • Whether FZD4 and junction/polarity proteins are direct EMC clients versus indirect consequences of ER stress not resolved
   • Each phenotype from a single lab
4. 2022 Medium

   Revealed a non-ER, mitotic function for EMC3 at centrosomes, identifying VCP-dependent control of Aurora A as a route to spindle and cell-cycle regulation.

   Evidence Conditional Emc3 deletion in mouse mesoderm, centrosomal immunofluorescence, gain/loss-of-function, and Western blotting of Aurora A levels and phosphorylation with VCP co-analysis

   PMID:36624844

   Open questions at the time

   • Molecular mechanism by which EMC3/VCP regulate Aurora A stability versus phosphorylation unresolved
   • Direct EMC3–Aurora A or EMC3–VCP physical interaction at centrosomes not biochemically mapped
5. 2024 High

   Connected EMC3 to VCP-mediated trafficking and disease, showing Emc3 loss rescues a pathogenic surfactant mutation and that VCP inhibition restores client trafficking.

   Evidence Affinity purification-MS, conditional Emc3 knockout in SFTPC-I73T knock-in mice, proteomics, and VCP inhibitor (CB5083) treatment in mice and patient iPSC-derived AT2 cells; intestinal knockout defining CFTR as a client

   PMID:39405113 PMID:39641142

   Open questions at the time

   • Precise biochemical interplay between EMC3 and VCP in client handling not defined
   • Whether CFTR is a direct EMC3 insertase substrate versus stabilization-dependent client not separated
6. 2025 Medium

   Broadened EMC3 client scope into lipid metabolism by identifying FITM2 as a client required for lipid droplet homeostasis and organismal fat storage.

   Evidence Liver- and adipose-specific conditional knockouts with proteomics, high-fat-diet challenge, and Drosophila dPob cross-species validation (preprint)

   Open questions at the time

   • Preprint, not yet peer-reviewed
   • Direct insertion of FITM2 by EMC3 not demonstrated biochemically

• How EMC3 reconciles its canonical ER insertase function with its centrosomal/cell-cycle role, and whether the diverse clients are recognized through a common structural determinant, remains unresolved.
• No structural model of EMC3 client engagement in the corpus
• Mechanism of EMC3 targeting to centrosomes versus ER not established
• No reconstituted insertase assay for any named client